Home/Filings/4/0001415889-25-005998
4//SEC Filing

ALEXANDER MARGARET A. 4

Accession 0001415889-25-005998

CIK 0001636651other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:15 PM ET

Size

5.1 KB

Accession

0001415889-25-005998

Insider Transaction Report

Form 4
Period: 2025-02-26
ALEXANDER MARGARET A.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2025-02-26$0.56/sh5,279$2,95673,406 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0002036798

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:15 PM ET
Size
5.1 KB